Author(s): Epstein MM
Abstract Share this page
Abstract Experimental mouse allergic asthma is a reliable, clinically relevant facsimile of human disease. The focus here is to demonstrate that antigen-induced mouse allergic asthma is a useful model for testing novel therapeutics. Furthermore, it is especially crucial to treat mice during established disease, either during ongoing clinically manifest disease or to prevent disease relapses. In addition, our results indicate that lung Th2 resting memory cells are important targets for the treatment of allergic asthma.
This article was published in Exp Toxicol Pathol
and referenced in Clinical Pharmacology & Biopharmaceutics